Market Research Industry Reports

MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MediGene AG (MediGene) is a biotechnology company which develops drugs for the treatment of various types and stages of cancer with candidates in clinical and pre-clinical development. The company focuses on the development of personalized T-cell-based immunotherapies. Its core business develops three immunotherapy platforms including DC vaccines to kill tumor cells; T-cell receptor (TCR) detects and kills tumor cells and T-cell-specific monoclonal antibodies (TABs), helps to remove unwanted T cells from the body. MediGene also has one marketed drug, Veregen for the treatment of genital warts. The company has operational presence in US, Europe and Asia. Medigene is headquartered in Martinsried, Germany.

MediGene AG Key Recent Developments

May 09,2018: Medigene reports First Quarter 2018 financials and provides operational update
Apr 11,2018: Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO/CDO
Mar 22,2018: Medigene publishes 2017 annual report
Mar 06,2018: Medigene strengthens its patent portfolio with a European patent covering T cell identification method
Feb 02,2018: Medigene strengthens its patent portfolio with a US patent on a tagged TCR

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Section 1 - About the Company 5
MediGene AG - Key Facts 5
MediGene AG - Key Employees 6
MediGene AG - Key Employee Biographies 7
MediGene AG - Major Products and Services 8
MediGene AG - History 9
MediGene AG - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 Company Analysis 17
Company Overview 17
MediGene AG - Business Description 18
MediGene AG - SWOT Analysis 19
SWOT Analysis - Overview 19
MediGene AG - Strengths 19
MediGene AG - Weaknesses 20
MediGene AG - Opportunities 21
MediGene AG - Threats 22
MediGene AG - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
MediGene AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
MediGene AG, Recent Deals Summary 32
Section 5 Companys Recent Developments 33
May 09, 2018: Medigene reports First Quarter 2018 financials and provides operational update 33
Apr 11, 2018: Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO/CDO 35
Mar 22, 2018: Medigene publishes 2017 annual report 36
Mar 06, 2018: Medigene strengthens its patent portfolio with a European patent covering T cell identification method 39
Feb 02, 2018: Medigene strengthens its patent portfolio with a US patent on a tagged TCR 40
Jan 19, 2018: Medigene announces participation at six upcoming investor and scientific conferences 41
Jan 04, 2018: Expitope 2.0 Helps to Identify Safer Antigens for Immunotherapy of Cancer 42
Dec 12, 2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing 43
Nov 09, 2017: Medigene Reports Nine Months Results 2017 45
Aug 25, 2017: Medigene Announces Participation At Five Upcoming Scientific And Investor Conferences 47
Section 6 Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52

List Of Tables


MediGene AG, Key Facts 5
MediGene AG, Key Employees 6
MediGene AG, Key Employee Biographies 7
MediGene AG, Major Products and Services 8
MediGene AG, History 9
MediGene AG, Subsidiaries 16
MediGene AG, Key Competitors 23
MediGene AG, Ratios based on current share price 24
MediGene AG, Annual Ratios 25
MediGene AG, Annual Ratios (Cont...1) 26
MediGene AG, Interim Ratios 28
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
MediGene AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
MediGene AG, Recent Deals Summary 32
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51

List Of Figures


MediGene AG, Performance Chart (2013 - 2017) 27
MediGene AG, Ratio Charts 29
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
MediGene AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review

MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it

USD 125View Report

MediGene AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

MediGene AG Company Profile is a detailed strategic and analytical report on MediGene AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

MediGene AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

MediGene AG Company Profile is a detailed strategic and analytical report on MediGene AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

MediGene AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

MediGene AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines MediGene AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Jul 2018
No. of Pages :52
Country :Germany
Category :Swot Analysis
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube